Recent Headlines
Within Biotechnology
AnaSpec Celebrates the Holidays with Its Customers
AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, EGT Group
Baxa to Sponsor Exhibitor’s Theatre: How to Get Your Administration to Buy What You Need: Building a Solid Business Plan 101 at ASHP
Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss key financial analyses and metrics and how to use them to build a compelling business plan. - November 27, 2007 - Baxa Corporation
Baxa to Sponsor Exhibitor’s Theatre: The Pros and Cons of Standardized Parenteral Nutrition at ASHP Midyear Clinical Meeting in Las Vegas
Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss parenteral nutrition safety issues and the differences between standardized formulations and a standardized process. - November 26, 2007 - Baxa Corporation
Gamma Medica-Ideas and Mayo Clinic Collaborate on New Breast Cancer Research Project
Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced its collaboration with Mayo Clinic in an important, new breast cancer research project. The main goal of the project, funded by a... - November 23, 2007 - Gamma Medica-Ideas
NovaBay Pharmaceuticals Featured in November/December Issue of PharmaVOICE
Company Executives Offer “Crystal Ball” Predictions. VP of Research Discusses Need for New Approaches in Anti-Infectives. - November 22, 2007 - NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. Retains The Investor Relations Group of New York
IRG to Communicate the Company’s Clinical Development Programs - November 21, 2007 - NovaBay Pharmaceuticals, Inc.
Baxa Corporation Signs Strategic Reseller Agreement with MedKeeper for Web-Based Productivity Tool
Baxa Corporation announces its agreement with MedKeeper to market and sell a Web-based program that tracks pharmacy doses from order entry to delivery. Under the agreement, Baxa Corporation has exclusive sales and distribution rights for all worldwide healthcare markets for the MedKeeper software. - November 21, 2007 - Baxa Corporation
BioCentury Editor Dr. Karen Bernstein Added to the Roster of National Speakers for The BioWest 2007 Conference and Expo
Karen Bernstein, Ph.D., Co-Founder, Chairman & Editor-in-Chief of the BioCentury family of publications, including the well-read “The Bernstein Report on Biobusiness” has been added to the roster of national speakers for BioWest 2007 on Thursday, December 6 (12:15 – 1 p.m.) at the Grand Hyatt Denver. Dr. Bernstein replaces Colorado Governor Bill Ritter for the Thursday luncheon address. The Governor's commitments required his speech be rescheduled to the 2:30 – 3 p.m. time slot the same day. - November 19, 2007 - Colorado BioScience Association
AnaSpec Introduces HiLytePlus™ Labeled Secondary Antibodies & Streptavidin
AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, EGT Group
Glycosan BioSystems Announces the Release of Extracel Sponge-96
Glycosan BioSystems launched its new product for cell-based assays Extracel Sponge-96. - November 15, 2007 - Glycosan BioSystems, Inc.
Baxa Corporation to Bring USP, ASHE and CAHED Together for a Joint Forum on USP 797 Compliance at the STAR Center
Baxa Corporation announces plans to launch new course offering with an industry forum on USP 797 compliance and facility design. The forum, held in the STAR (Skills Training, Academics and Resources) Center, will bring together industry leaders to better understand the requirements of USP 797 and their practical application for facility design and environmental control. - November 14, 2007 - Baxa Corporation
Clinical Trials in Russia, 3rd Quarter 2007
According to SynRG Orange Paper, in the 3rd Quarter 2007, the overall volume of the clinical trials in Russia and its basic parameters are generally the same as in the corresponding quarter of the last year. In the 3rd Quarter 2007 RosZdravNadzor (RZN) has issued 141 approvals for conducting new clinical trials, which is 2% more than in Q3 2006. - November 14, 2007 - Synergy Research Group
Five Top Colorado Bioscience Company CEOs Present at This Year’s BioWest Mature Company Forum
CEOs from five of Colorado’s top bioscience companies will present at the BioWest 2007 Mature Company Forum on December 6th – registration is still open for the two-day BioWest event, which is the Rocky Mountain Region’s premier bioscience conference and expo. CEOs featured in the Mature Company Forum include Bob Conway, Array Biopharma; Greg Baldwin, Baxa Corporation; Jeff Probst, Blue Sun Biodiesel; Chris Smith, Cochlear Americas; and Bob Grieve, Heska Corporation. - November 12, 2007 - Colorado BioScience Association
AnaSpec Introduces Thirteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death... - November 11, 2007 - AnaSpec, EGT Group
AnaSpec Introduces HiLytePlus™ – AnaSpec’s Highest Performance Fluorescent Dyes
This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec’s HiLyte Fluor™ line, this series represents the next generation in AnaSpec’s line of high performance fluorescent dyes. With excitation... - November 09, 2007 - AnaSpec, EGT Group
Six Finalists Selected for the BioWest 2007 Venture Showcase Competition, Presenting World-Changing Technologies
Novel diagnostics focusing on the management of therapeutics, innovative nanoscale drug and vaccine delivery technology, pioneering use of small molecule therapeutic products for treating multiple diseases of the brain, cutting edge technology for the production of algae-based biofuels, new... - November 02, 2007 - Colorado BioScience Association
Xcelience’s Scientific Director Selected to Lead Key Sessions on Upcoming Conferences
Dr. Steve Bannister’s expertise requested for several speaking engagements over the next year - October 31, 2007 - Xcelience, LLC
AnaSpec Introduces Anti-Keratin-18 & 19 Antibodies
AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the... - October 24, 2007 - AnaSpec, EGT Group
Glycosan BioSystems, Inc. to Attend AACR Molecular Targets and Cancer Therapeutics
Glycosan BioSystems, Inc. a manufacturer of innovative products for three-dimensional cell culture, will be attending the American Association for Cancer Research's Molecular Targets and Cancer Therapeutics conference to be held in San Francisco on October 22-26, 2007. - October 19, 2007 - Glycosan BioSystems, Inc.
AnaSpec Introduces Labeled RGD Peptide for In Vivo Imaging
Leveraging its dual expertise in peptides and detection reagents, AnaSpec has released c[RGDyK(HiLyte FluorTM 750)], a labeled RGD peptide that has produced significant imaging results in a recent in vivo research study. Extracellular matrix proteins containing the Arg-Gly-Asp (RGD) motif, and... - October 18, 2007 - AnaSpec, EGT Group
AnaSpec Introduces One New Amino Acid and Two New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced one new unusual amino acid and two new catalog peptides. HRP Prorenin; Decoy Handle Region Peptide- Cat# 62118 Sequence: RILLKKMPSV Fmoc-HomoArg(Pbf)-OH- Cat# 60004-1/ 60004-5 TP508;... - October 17, 2007 - AnaSpec, EGT Group
Nanion's Technology Nominated for Presidential Innovation Award
Nanion's Planar Patch Clamp Technology has been nominated for the German Future Award 2007 - October 13, 2007 - Nanion Technologies GmbH
Dr. William Heyward on the Forefront of the Fight Against the World's Deadliest Communicable Diseases
For nearly three decades, William Heyward has been on the forefront in the fight against some of the world's deadliest communicable diseases. HIV/AIDS, Ebola, haemophilius influenzae, hepatitis B, and hepatic cancer are among the many illnesses he has focused his attention on in places as far-flung as Zaire, Alaska, South America and Thailand. Dr. Heyward has lived on the leading edge of research on the causes, effects and prevention of devastating diseases among some of the world's poorest area - October 12, 2007 - William Heyward
AnaSpec Launches New SensoLyteTM Caspase-8 Assay Kit
AnaSpec introduces its newest offering – the SensoLyte™ Homogeneous AFC Caspase-8 Assay Kit - October 11, 2007 - AnaSpec, EGT Group
Baxa Corporation Launches PadLock™ Set Saver for IV Safety
Baxa Corporation’s New PadLock Set Saver locks in IV safety through its unique design. PadLock is the first and only aseptic IV administration set storage solution that can be swabbed and re-used. Effective for multiple uses, the Set Saver attaches to an IV administration set and replaces the need for sterile, single-use caps. - October 10, 2007 - Baxa Corporation
Better Stem Cell Culture
Extracel-HP makes stem cell culture more realistic - October 07, 2007 - Glycosan BioSystems, Inc.
AnaSpec Introduces Improved Website Search Tool
AnaSpec has introduced Smart Search, an optimized site search engine for locating items in AnaSpec’s expansive collection of products. - October 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Anti-Keratin-18 & 19 Antibodies
AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the... - October 06, 2007 - AnaSpec, EGT Group
Baxa Corporation Recognized with Art Directors Club of Denver Merit Award
A Baxa Corporation Internet microsite, designed to promote the Rapid-Fill Automated Syringe Filler, wins merit award from Art Directors Club of Denver. The Art Directors Club of Denver Annual Show features the best examples of marketing communications from across the Front Range. Nationally recognized judges from Seattle, Minneapolis, Birmingham and Kansas City participated in awarding more than 100 entries in this year’s program. - October 04, 2007 - Baxa Corporation
AnaSpec Introduces Fifteen New Catalog Peptides
AnaSpec introduced fifteen (15) new peptides for drug discovery research. - October 04, 2007 - AnaSpec, EGT Group
Gamma Medica-Ideas Announces Sale of Two Pre-clinical Imaging Systems to Switzerland’s Centre d’Imagerie Biomédicale
Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, announced today that the Centre d’Imagerie Biomédicale (CIBM) in Lausanne, Switzerland, has taken delivery of two of GM-I’s... - October 04, 2007 - Gamma Medica-Ideas
AnaSpec Has Introduced a Collection of Dye-Labeled Amino Acids and Resins
AnaSpec, one of the world’s leading providers of dye-labeled and FRET (fluorescent resonance energy transfer) peptides, has introduced a collection of dye-labeled amino acids and resins. Already conjugated with fluorescent dyes or quencher molecules, these ready-to-use building blocks... - September 27, 2007 - AnaSpec, EGT Group
Colorado BioScience Association Commends Governor Ritter for Supporting Creation of New Bioscience Companies and Fostering Retention of 400+ Existing Firms
The Colorado BioScience Association (CBSA) commends Governor Ritter for crafting an economic development agenda for 2008 that will spur the creation of new bioscience companies and help the state retain the 400 plus companies that exist today. The restructuring of the corporate income tax to a system based on in-state sales will make Colorado competitive with others states that understand the value of high-paying technology-based jobs. - September 27, 2007 - Colorado BioScience Association
AnaSpec Introduces Nine New Catalog Peptides
AnaSpec introduced nine (9) new peptides for drug discovery research - September 26, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Nine New Catalog Antibodies
Continuing in its commitment to expand its antibody offerings, AnaSpec added nine (9) new antibodies to its growing collection of catalog antibodies. Anti-Estrogen Receptor-alpha (Paired 167) - Cat# 28002, 50 µg Host: rabbit polyclonal; Species Reactivity: human; monkey; chimpanzees;... - September 23, 2007 - AnaSpec, EGT Group
Best-Selling Author Jim Collins Headlines Stellar Lineup of National Presenters for the 2007 BioWest Conference and Expo, Now Open for Registration
Registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2007. More than 900 participants are expected at this year’s event, December 6-7, at the Grand Hyatt in Denver. Best-selling author & noted management scholar Jim Collins headlines a stellar lineup of national presenters for BioWest 2007. - September 21, 2007 - Colorado BioScience Association
Baxa Corporation Extends Global Reach with New Distribution Agreements in Colombia and the Dominican Republic
Baxa announces the addition of new exclusive distributors in Colombia, South America, and The Dominican Republic. These agreements – with Magallan Pharma Trading Corporation in Colombia and Pentafarma & Co. in The Dominican Republic – will enable Baxa to extend its global reach and expand product promotion in South America and the Caribbean. Baxa products are sold worldwide both direct and through exclusive distribution arrangements. - September 21, 2007 - Baxa Corporation
AnaSpec Introduces New Anti-LC Antibodies
AnaSpec has introduced its newest collection of Anti-LC antibodies that can be used as autophagosome markers. - September 21, 2007 - AnaSpec, EGT Group
Gamma Medica-Ideas Announces Installation of Digital CZT Detectors for Pre-Clinical Imaging at Oklahoma Medical Research Foundation
Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, announced today that it has forged ahead with yet another installation of its new digital CZT detectors for SPECT. The Oklahoma Medical Research... - September 21, 2007 - Gamma Medica-Ideas
AnaSpec Introduces Thirty-Two New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-two (32) new peptides for drug discovery research. - September 16, 2007 - AnaSpec, EGT Group
IQbase Image Database Version 2.5 Lets Users Manage and Share Large Numbers of Images and Data
IQbase 2.5 is a powerful image management solution that helps organizations to store, query, and share large numbers of scientific images and data. Users can share images via the web and through their internal networks. - September 16, 2007 - Media Cybernetics
Russian and Indian CROs Announce Network Alliance for Expansion of Global Clinical Trials Services
On September 12, 2007 Synergy Research Group (SynRG), a Russia-based CRO with more than 5-years experience in clinical trials in Russia announced the establishment of a new CRO Worldwide Network alliance with Neeman Medical International (NMI), an India-based CRO. This is the second step made by... - September 14, 2007 - Synergy Research Group
AnaSpec Introduces Industry’s First ACE2 Activity Assay Kit
With its reported relation to cardiovascular disease, kidney disease, and severe acute respiratory syndrome (SARS), Angiotensin I converting enzyme 2 (ACE2) has become an increasingly important therapeutic target. - September 12, 2007 - AnaSpec, EGT Group
Glycosan BioSystems, Inc. is Proud to Announce the Release of Extracel-LG for Stem Cell Applications
Glycosan BioSystems creates a unique extracellular matrix for animal-free stem cell culturing. - September 08, 2007 - Glycosan BioSystems, Inc.
Gamma Medica-Ideas Announces Three Appointments to Its Highly Experienced Multidisciplinary Management Team
Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, announced today three executive appointments to its Multidisciplinary Management Team. Dr. Samir Chowdhury has been named Senior Vice President... - September 07, 2007 - Gamma Medica-Ideas
AnaSpec Introduces New Kinase Peptide Library
AnaSpec, the key supplier of kinase peptide libraries mentioned in the articles, has announced the worldwide commercial availability of its newest kinase peptide library. - September 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Fifty-Five New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fifty-five (55) new peptides for drug discovery research. - September 05, 2007 - AnaSpec, EGT Group
BioWest 2007 Organizers Seek the Best and Brightest of the Rocky Mountain Region’s Bioscience Start-Ups for the Venture Showcase Competition
BioWest, The Rocky Mountain Region’s Premier Bioscience Conference and Expo, is again looking for the best bioscience start-ups in the region as candidates for the $10,000 Faegre & Benson Venture Showcase Award. Six companies will be chosen to present at the Showcase in December, which will be judged by a panel of national venture capitalists. Deadline for entry is September 28, 2007. - August 30, 2007 - Colorado BioScience Association
New Labeled Antibodies: Anti-CD-3ε, Anti-CD79α
Leveraging its expertise in both detection reagents and antibodies, AnaSpec has introduced a new series of labeled Anti-CD-3ε and anti-CD79α antibodies. - August 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Thirty-Six New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-six (36) new peptides for drug discovery research. Protease-Activated Receptor-4; PAR-4 Agonist; amide; human Amyloid Precursor Protein (APP) (667-676); Swedish mutation Colivelin AGA-(C8R)... - August 28, 2007 - AnaSpec, EGT Group